Literature DB >> 28887752

Comparison of Antipyretic Efficacy of Intravenous (IV) Acetaminophen versus Oral (PO) Acetaminophen in the Management of Fever in Children.

Shuvendu Roy1, A K Simalti2.   

Abstract

OBJECTIVE: To assess the dynamics of the onset of antipyretic efficacy of intravenous (IV) acetaminophen vs. oral (PO) acetaminophen in the management of fever in children.
METHODS: This observational single-dose study was conducted at Department of Pedriatrics, Army Hospital (Research and Referral), a multispecialty tertiary care center in New Delhi in fever patients to assess the antipyretic efficacy of IV acetaminophen 15 mg/kg/dose vs. PO acetaminophen 15 mg/kg/dose over 6 h. Subjects were randomly assigned to receive either IV acetaminophen (n = 200) or PO acetaminophen (n = 200).
RESULTS: Demographics and baseline characteristics were similar between the two groups and were normally distributed. Allergic reaction was found in 7 (3.5%) patients in IV acetaminophen group and was absent in PO acetaminophen group. Onset of constipation and dry mouth was found in 8 patients (4%) in IV acetaminophen group and was absent in PO acetaminophen group. Additional dose was required in 6 patients (3%) in intravenous acetaminophen group and 10 patients (5%) in oral acetaminophen group respectively. Statistically significant differences in the rate of fall in temperature through 180 min were observed in favor of the IV acetaminophen group when compared to those receiving PO acetaminophen.
CONCLUSIONS: A single dose of intravenous acetaminophen is safe and effective in reducing fever where patients are unable to tolerate oral administration or when rapid reduction of temperature is desirable.

Entities:  

Keywords:  Acetaminophen; Fever; Intravenous; Oral; Paracetamol; Pediatrics

Mesh:

Substances:

Year:  2017        PMID: 28887752     DOI: 10.1007/s12098-017-2457-3

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  17 in total

1.  A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever.

Authors:  W Frank Peacock; James B Breitmeyer; Christine Pan; William B Smith; Mike A Royal
Journal:  Acad Emerg Med       Date:  2011-04       Impact factor: 3.451

2.  The pharmacokinetics and analgesic efficacy of larger dose rectal acetaminophen (40 mg/kg) in adults: a double-blinded, randomized study.

Authors:  D H Beck; M R Schenk; K Hagemann; U R Doepfmer; W J Kox
Journal:  Anesth Analg       Date:  2000-02       Impact factor: 5.108

3.  Pharmacokinetics and clinical efficacy of intrarectal solution of acetaminophen.

Authors:  P Gaudreault; J Guay; O Nicol; C Dupuis
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

4.  Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial.

Authors:  T Pernerstorfer; R Schmid; C Bieglmayer; H G Eichler; S Kapiotis; B Jilma
Journal:  Clin Pharmacol Ther       Date:  1999-07       Impact factor: 6.875

5.  Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration.

Authors:  Elina Kumpulainen; Hannu Kokki; Toivo Halonen; Marja Heikkinen; Jouko Savolainen; Merja Laisalmi
Journal:  Pediatrics       Date:  2007-04       Impact factor: 7.124

6.  A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients.

Authors:  Michael E Mullins; Matthew Empey; David Jaramillo; Sameta Sosa; Theresa Human; Michael N Diringer
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

7.  Short-term outcomes of pediatric emergency department febrile illnesses.

Authors:  Rakesh D Mistry; Molly W Stevens; Marc H Gorelick
Journal:  Pediatr Emerg Care       Date:  2007-09       Impact factor: 1.454

8.  Plasma concentrations after high-dose (45 mg.kg-1) rectal acetaminophen in children.

Authors:  C J Montgomery; J P McCormack; C C Reichert; C P Marsland
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

9.  Relative bioavailability and plasma paracetamol profiles of Panadol suppositories in children.

Authors:  K P Coulthard; H W Nielson; M Schroder; A Covino; N T Matthews; R S Murray; J H Van Der Walt
Journal:  J Paediatr Child Health       Date:  1998-10       Impact factor: 1.954

Review 10.  Intravenous paracetamol (acetaminophen).

Authors:  Sean T Duggan; Lesley J Scott
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more
  5 in total

1.  Newly approved IV acetaminophen in Canada: Switching from oral to IV acetaminophen. Is IV worth the price difference? A systematic review.

Authors:  Maxime Ulrich; Martine Chamberland; Christel Bertoldi; Facundo Garcia-Bournissen; Niina Kleiber
Journal:  Paediatr Child Health       Date:  2021-03-13       Impact factor: 2.253

2.  Synergistic interaction between acetaminophen and L-carnosine improved neuropathic pain via NF-κB pathway and antioxidant properties in chronic constriction injury model.

Authors:  Bamidele Victor Owoyele; Ahmed Olalekan Bakare; Olutayo Folajimi Olaseinde; Mohammed Jelil Ochu; Akorede Munirdeen Yusuff; Favour Ekebafe; Oluwadamilare Lanre Fogabi; Treister Roi
Journal:  Korean J Pain       Date:  2022-07-01

3.  Rectal diclofenac versus high-dose rectal acetaminophen in children: A randomized clinical trial.

Authors:  Houman Hashemian; Marzie Fallah Khodadoost
Journal:  Caspian J Intern Med       Date:  2021-03

Review 4.  Management of acute fever in children: Consensus recommendations for community and primary healthcare providers in sub-Saharan Africa.

Authors:  Robin Green; David Webb; Prakash Mohan Jeena; Mike Wells; Nadia Butt; Jimmy Mapenzi Hangoma; Rajatheran Sham Moodley; Jackie Maimin; Margreet Wibbelink; Fatima Mustafa
Journal:  Afr J Emerg Med       Date:  2021-04-10

Review 5.  From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis.

Authors:  Charlotte Quintens; Marie Coenen; Peter Declercq; Minne Casteels; Willy E Peetermans; Isabel Spriet
Journal:  BMJ Open       Date:  2022-04-08       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.